Abnormal NF-κB activation may be caused by high levels of cytokines, microRNAs, genetic alternation of NF-κB itself or genes related to signaling, and over-activation of signaling in prostate cancer [79,80,81,82,83]. The gene discussed is NFKB1; the disease is prostate carcinoma.